Eurofins Scientific SE
ERF
Rank in Stocks
#1377
Eurofins Scientific SE, together with its subsidiaries, provides various... Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection, QA-QC programme, and food and dietary supplement labelling services; biopharma, and clinical diagnostics. The company also offers consumer product testing, which include sustainability, testing, certifications and approvals, expert services and regulatory, inspections, audits, consumer research and sensory evaluation, and training courses; cosmetics and personal care; and electrical and electronics laboratories services. In addition, it provides environment testing, including maritime, water, air, soil, building material, pollution, waste, fuel/oil, microplastics, and radioactivity testing; and food and feed testing that include allergen, audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, GMO, heavy metal, melamine, microbiology, molecular biology, mycotoxin, nutritional analyses, organic contaminants, pesticide, veterinary drug, vitamin, and residual DNA testing. Further, the company provides forensic, genomic, maritime, materials and engineering, REACH, and sensory and consumer services, as well as in vitro diagnostics and PSS insourcing solutions. The company was founded in 1987 and is headquartered in Luxembourg, Luxembourg.
Share Price
$93.33
Market Cap
$16.20B
Change (1 day)
-0.33%
Change (1 year)
25.44%
Country
LU
Trade Eurofins Scientific SE (ERF)
Category
Healthcare
P/E ratio for Eurofins Scientific SE (ERF)
P/E ratio as of October 2026 TTM: 25.95
According to Eurofins Scientific SE latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 25.95. At the end of 2024 the company had a P/E ratio of 23.13.
P/E ratio history for Eurofins Scientific SE from 2002 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 25.95 | 9.74% |
| 2025 | 23.65 | 2.25% |
| 2024 | 23.13 | -36.93% |
| 2023 | 36.67 | 73.31% |
| 2022 | 21.16 | -20.54% |
| 2021 | 26.62 | 12.38% |
| 2020 | 23.69 | -47.43% |
| 2019 | 45.07 | 74.87% |
| 2018 | 25.77 | -36.00% |
| 2017 | 40.27 | 8.19% |
| 2016 | 37.22 | -33.98% |
| 2015 | 56.37 | 38.99% |
| 2014 | 40.56 | -0.63% |
| 2013 | 40.82 | 50.69% |
| 2012 | 27.09 | 86.10% |
| 2011 | 14.55 | -55.58% |
| 2010 | 32.76 | -168.24% |
| 2009 | -48.01 | -270.41% |
| 2008 | 28.17 | -55.04% |
| 2007 | 62.67 | 45.55% |
| 2006 | 43.06 | 3.50% |
| 2005 | 41.60 | 44.58% |
| 2004 | 28.77 | -65.77% |
| 2003 | 84.05 | -92.15% |
| 2002 | 1.07K | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 36.15 | 39.31% |
US
|
|
| 39.77 | 53.25% |
US
|
|
| -290.26 | -1,218.38% |
US
|
|
| - | - |
CN
|
|
| 34.18 | 31.72% |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.